SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  Research and Markets: United States Market for In Vitro Diagnostic Tests Report 2014-2018

[July 23, 2014]

Research and Markets: United States Market for In Vitro Diagnostic Tests Report 2014-2018

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/npt9tk/the_united_states) has announced the addition of the "The United States Market for In Vitro Diagnostic Tests" report to their offering.

Advanced flow cytometry and microbiology tests will provide more opportunity for manufacturers than POC tests or clinical chemistry test products sold in the United States. A Relative Opportunity Metric is used to assess the segments of clinical lab testing in the world's largest healthcare market.

According to the report, Market growth remains robust for U.S. microbiology diagnostics, a group of IVD segments including traditional microbiology (culturing for ID/AST), rapid tests, molecular infectious disease tests, and immunoassay infectious disease tests. Several market drivers exist for microbiology in the United States: hospital investment i microbiology for health-acquired infection (HAI) testing, investment in automated microbiology systems, rising rates of incidence for several sexually transmitted diseases (STDs), and market penetration by higher-priced molecular infectious disease tests.


The report also indicates that advanced IVD tests in this study, including molecular assays for non-infectious disease testing, histology, cytology, and flow cytometry. Molecular assays and histology are projected to be the two-fastest growing IVD market segments in the United States through 2018. Tissue analysis or histology in support of cancer diagnosis and treatment is increasingly reliant on immunohistochemical (IHC) reagents and molecular hybridization (ISH/FISH) techniques and represents a fast rising market in the aging United States. The United States is also ground zero for an influx of advanced molecular assays for blood-based cancer testing, circulating tumor cell (CTC (News - Alert)) testing, pharmacodiagnostics, and other sequencing-developed tests.

The report, The United States Market for In Vitro Diagnostic Tests, contains further detail on the US IVD market including segment markets and forecasts, corporate profiles, and other information.

Key Topics Covered:

Chapter One: Executive Summary

Chapter Two: Introduction To U.S. Health Care

Chapter Three: U.S. Ivd Market Analysis

Chapter Four: Top Tier U.S. Ivd Market Players

  • Abbott Diagnostics
  • Alere
  • Beckman Coulter
  • Becton Dickinson
  • Danaher Corporation (News - Alert)
  • Hologic
  • Ortho-Clinical Diagnostics / J&J Diabetes Care
  • QIAGEN
  • Roche Diagnostics
  • Siemens (News - Alert) Healthcare Diagnostics
  • Sysmex Corporation
  • Thermo Fisher Scientific

For more information visit http://www.researchandmarkets.com/research/npt9tk/the_united_states


[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved | Privacy Policy